BACKGROUND: Much of the interindividual variation in left ventricular (LV) structure and function is unexplained by established risk factors and may be due to novel or genetic factors. We used pedigree information from 454 tandem markers across the genome to estimate the heritability and linkage of various echocardiographic measures of LV structure and function in a cohort of African-American hypertensive siblings. METHODS: LV mass was calculated according to the American Society of Echocardiography (ASE) simplified cubed equation and indexed to height(2.7). Fractional shortening (FS) was calculated as the percent change in the internal diameter between diastole and systole. Ejection fraction (EF) was calculated from ventricular diameters. Peak mitral early and late diastolic filling velocities were measured from the transmitral pulsed Doppler profile. The maximum-likelihood heritability estimate for each phenotype was obtained using a variance components method. Linkage analyses were performed using the multipoint variance components-based approach. RESULTS: There was moderate heritability for LV mass index (34%), interventricular septal thickness (29%), diastolic diameter (42%), EF (40%), FS (39%), and mitral early and late diastolic filling velocities (37 and 45%, respectively). The greatest evidence of genetic linkage was observed for LV mass index on chromosome 3 (logarithm of odds (LOD) score = 2.38), LV EF on chromosome 12 (LOD score = 2.39), and mitral E-wave velocity (MVE) on chromosome 19 (LOD score = 2.69). CONCLUSIONS: In this African-American cohort of hypertensive siblings, the greatest evidence for linkage of LV structure and function was on chromosomes 3, 12, and 19.
BACKGROUND: Much of the interindividual variation in left ventricular (LV) structure and function is unexplained by established risk factors and may be due to novel or genetic factors. We used pedigree information from 454 tandem markers across the genome to estimate the heritability and linkage of various echocardiographic measures of LV structure and function in a cohort of African-American hypertensive siblings. METHODS: LV mass was calculated according to the American Society of Echocardiography (ASE) simplified cubed equation and indexed to height(2.7). Fractional shortening (FS) was calculated as the percent change in the internal diameter between diastole and systole. Ejection fraction (EF) was calculated from ventricular diameters. Peak mitral early and late diastolic filling velocities were measured from the transmitral pulsed Doppler profile. The maximum-likelihood heritability estimate for each phenotype was obtained using a variance components method. Linkage analyses were performed using the multipoint variance components-based approach. RESULTS: There was moderate heritability for LV mass index (34%), interventricular septal thickness (29%), diastolic diameter (42%), EF (40%), FS (39%), and mitral early and late diastolic filling velocities (37 and 45%, respectively). The greatest evidence of genetic linkage was observed for LV mass index on chromosome 3 (logarithm of odds (LOD) score = 2.38), LV EF on chromosome 12 (LOD score = 2.39), and mitral E-wave velocity (MVE) on chromosome 19 (LOD score = 2.69). CONCLUSIONS: In this African-American cohort of hypertensive siblings, the greatest evidence for linkage of LV structure and function was on chromosomes 3, 12, and 19.
Authors: Weihong Tang; Donna K Arnett; Richard B Devereux; Larry D Atwood; Dalane W Kitzman; Dabeeru C Rao Journal: Am J Hypertens Date: 2002-07 Impact factor: 2.689
Authors: D K Arnett; R B Devereux; D Kitzman; A Oberman; P Hopkins; L Atwood; A Dewan; D C Rao Journal: Hypertension Date: 2001-10 Impact factor: 10.190
Authors: Sharon L R Kardia; Laura S Rozek; Julia Krushkal; Robert E Ferrell; Stephen T Turner; Richard Hutchinson; Andrew Brown; Charles F Sing; Eric Boerwinkle Journal: Am J Hypertens Date: 2003-02 Impact factor: 2.689
Authors: Weihong Tang; Donna K Arnett; Richard B Devereux; Michael A Province; Larry D Atwood; Albert Oberman; Paul N Hopkins; Dalane W Kitzman Journal: Hypertension Date: 2002-09 Impact factor: 10.190
Authors: Richard B Devereux; Giovanni de Simone; Donna K Arnett; Lyle G Best; Eric Boerwinkle; Barbara V Howard; Dalane Kitzman; Elisa T Lee; Thomas H Mosley; Alan Weder; Mary J Roman Journal: Am J Cardiol Date: 2012-07-06 Impact factor: 2.778
Authors: Hélène Choquet; Khanh K Thai; Chen Jiang; Dilrini K Ranatunga; Thomas J Hoffmann; Alan S Go; Alistair C Lindsay; Margaret G Ehm; Dawn M Waterworth; Neil Risch; Catherine Schaefer Journal: Circ Genom Precis Med Date: 2020-06-30
Authors: Vernice R Peterson; Gavin R Norton; Michelle Redelinghuys; Carlos D Libhaber; Muzi J Maseko; Olebogeng H I Majane; Richard Brooksbank; Angela J Woodiwiss Journal: Am J Hypertens Date: 2014-11-05 Impact factor: 2.689
Authors: Cesare Russo; Zhezhen Jin; Shunichi Homma; Tatjana Rundek; Mitchell S V Elkind; Ralph L Sacco; Marco R Di Tullio Journal: Am Heart J Date: 2015-02-21 Impact factor: 4.749
Authors: David Della-Morte; Ashley Beecham; Tatjana Rundek; Liyong Wang; Mark S McClendon; Susan Slifer; Susan H Blanton; Marco R Di Tullio; Ralph L Sacco Journal: BMC Med Genet Date: 2011-07-26 Impact factor: 2.103
Authors: Marguerite R Irvin; Praful Aggarwal; Steven A Claas; Lisa de Las Fuentes; Anh N Do; C Charles Gu; Andrea Matter; Benjamin S Olson; Amit Patki; Karen Schwander; Joshua D Smith; Vinodh Srinivasasainagendra; Hemant K Tiwari; Amy J Turner; Deborah A Nickerson; Dabeeru C Rao; Ulrich Broeckel; Donna K Arnett Journal: Front Genet Date: 2021-02-19 Impact factor: 4.599